IP Library Granted Patent US 10,653,888
Granted Patent B2
US 10,653,888 · App. 15/638,924 · Granted May 19, 2020

Wireless neurostimulators

Inventors: Guri Oron (Tel Aviv, IL); Yossi Gross (Moshav Mazor, IL); Danny Neeman (Ramat Hasharon, IL); Shlomo Ronen (Raanana, IL)
Assignee: BLUEWIND MEDICAL LTD
A61N1/3787A61N1/36139A61N1/36167A61N1/375A61N1/37205A61N5/022A61N5/04A61H23/00A61N1/0556A61N1/36067A61N1/36071A61N1/3756A61N1/37288
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,653,888
App. No.
15/638,924
Granted
May 19, 2020
Kind
B2
Abstract

A subcutaneous implant, including: (a) a circuitry unit having a first end, a second end, a conducting lateral side, and an opposing lateral side; (b) a first electrode, disposed on an outer surface of the circuitry unit and laterally circumscribing the circuitry unit at the first end; (c) a second electrode, disposed on the outer surface of the circuitry unit and laterally circumscribing the circuitry unit at the second end; (d) circuitry, disposed within the circuitry unit, and configured to be wirelessly powered to drive an electrical current between the electrodes; and (e) an insulating member, disposed on the opposing lateral side such that, on the opposing lateral side, each electrode is sandwiched between the insulating member and the circuitry unit, and the insulating member inhibits electrical conduction from the electrodes into the tissue. Other embodiments are also described.

Claims (24)

1. Apparatus for use with tissue of a subject, the apparatus comprising a subcutaneous implant, the subcutaneous implant comprising:

a circuitry unit having a first end, a second end, a conducting lateral side, and an opposing lateral side, and defining a longitudinal axis between the first and second ends;

a first electrode, disposed on an outer surface of the circuitry unit and laterally circumscribing the circuitry unit at the first end;

a second electrode, disposed on the outer surface of the circuitry unit and laterally circumscribing the circuitry unit at the second end;

circuitry, disposed within the circuitry unit, and configured to be wirelessly powered to drive an electrical current between the first and second electrodes; and

an insulating member, disposed on the opposing lateral side of the circuitry unit such that, on the opposing lateral side, each electrode is covered by a laterally-inner part of the insulating member by being sandwiched between the laterally-inner part of the insulating member and the circuitry unit, and the laterally-inner part of the insulating member inhibits electrical conduction from the electrodes into the tissue,

wherein:

laterally-outer parts of the insulating member extend laterally outward away from the laterally-inner part of the insulating member and from the circuitry unit to define:

a first lateral zone along a first lateral edge of the circuitry unit, the first lateral zone extending laterally outward away from the circuitry unit, and

a second lateral zone along a second lateral edge of the circuitry unit, the second lateral zone extending laterally outward away from the circuitry unit, and

no electrodes of the implant are disposed in the first lateral zone or the second lateral zone.

2. The apparatus according to claim 1 , wherein the implant does not comprise a power supply that is able to continuously power the implant for a period greater than one minute.

3. The apparatus according to claim 1 , wherein the implant is configured such that the driving of the electrical current does not induce contraction of a muscle of the subject.

4. The apparatus according to claim 1 , further comprising a transmitting unit, configured to transmit wireless power, and wherein the implant is configured to receive the wireless power.

5. The apparatus according to claim 4 , wherein the implant is configured to apply the treatment in response to receiving the wireless power.

6. The apparatus according to claim 4 , wherein the implant is configured to apply the treatment only when the implant receives the wireless power.

7. The apparatus according to claim 1 , wherein the circuitry unit has a prismatic shape that has a length, from the first end to the second end, of 5-50 mm.

8. The apparatus according to claim 7 , wherein the length of the circuitry unit is 10-30 mm.

9. The apparatus according to claim 7 , wherein the circuitry unit is 1-5 mm in width.

10. The apparatus according to claim 9 , wherein the circuitry unit is 1.5-3 mm in width.

11. The apparatus according to claim 1 , wherein a width of each lateral zone is greater than 1 mm.

12. The apparatus according to claim 11 , wherein a width of each lateral zone is greater than 2 mm.

13. The apparatus according to claim 12 , wherein a width of each lateral zone is greater than 5 mm.

14. The apparatus according to claim 1 , wherein the insulating member comprises insulating silicone.

Assignments (2)
SECURITY INTEREST Recorded May 6, 2026
From: BLUEWIND MEDICAL LTD.; BLUEWIND MEDICAL INC.
To: CONVATEC INTERNATIONAL UK LIMITED
Reel/Frame 074577/0280 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2020
From: ORON, GURI; GROSS, YOSSI; NEEMAN, DANNY; RONEN, SHLOMO
To: BLUEWIND MEDICAL LTD.
Reel/Frame 051867/0739 →
Continuity (4)
Continuation 14374375
Provisional Application 61591024 · Jan 26, 2012
Provisional Application 61662073 · Jun 20, 2012
Related Publication 20170296426A1 · Oct 19, 2017
Cited By (3)
US 12,434,063 US 12,569,692 US 12,582,767